Research Archive — Page 30 of 131
-
March 7, 2024
Study details metabolism of biomarkers for oxidative stress
Factors other than oxidative stress can modify the levels of biomarkers called isoprostanes that are commonly used in both experimental and clinical research, suggesting that additional standards need to be developed. -
March 7, 2024
Blood mutations increase risk for acute kidney injury: study
A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide. -
March 4, 2024
Dame Frances Ashcroft to deliver March 21 Vanderbilt Prize Lecture
Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, March 21, in 208 Light Hall. -
February 27, 2024
Multi-institutional study of Wilms tumor facilitates enrollment, optimizes treatment
Multi-institutional study finds that enrollment and outcomes were similar across various groups of children participating in therapeutic trials for Wilms tumor — the most common pediatric kidney cancer worldwide. -
February 22, 2024
AI aids efforts to cut nuisance alerts for health care teams: study
A new study from Vanderbilt University Medical Center demonstrates the promise of artificial intelligence to help refine and target the myriad computerized alerts intended to assist doctors and other team members in day-to-day clinical decision-making. -
February 21, 2024
International genetic study of glaucoma implicates vascular and cancer-related genes
An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally. -
February 19, 2024
VUMC part of major step to achieving precision medicine
An analysis of genomic data from nearly 250,000 participants in the National Institutes of Health’s All of Us Research Program has identified more than 275 million previously unreported genetic variations, nearly 4 million of which have potential health consequences.